A clinical trial of Aflibercept biosimilar
Latest Information Update: 05 Dec 2022
At a glance
- Drugs Aflibercept (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
Most Recent Events
- 05 Dec 2022 New trial record
Latest Information Update: 05 Dec 2022